自身免疫性肝病并发腹腔淋巴结肿大的临床特征分析

张璐; 刘丽娜

doi:10.3969/j.issn.1001-5256.2017.11.025

自身免疫性肝病并发腹腔淋巴结肿大的临床特征分析

DOI: 10.3969/j.issn.1001-5256.2017.11.025

张璐,
刘丽娜

大连医科大学附属第一医院消化内科

详细信息

中图分类号: R575
计量
- 文章访问数: 2242
- HTML全文浏览量: 15
- PDF下载量: 400
- 被引次数: 0
出版历程
- 收稿日期: 2017-05-09
- 出版日期: 2017-11-20

Clinical features of autoimmune liver disease complicated by abdominal lymphadenectasis

Zhang Lu,
Liu LiNa

Department of Gastroenterology, The First Affiliated Hospital of Dalian Medical University

摘要

摘要:
目的探讨自身免疫性肝病（AILD）合并腹腔淋巴结肿大（LA）患者的临床特征及LA在AILD诊断中的临床意义。方法回顾性分析2005年1月-2016年4月大连医科大学附属第一医院收治的252例AILD患者的病例资料,其中自身免疫性肝炎（AIH）患者52例,原发性胆汁性胆管炎（PBC）患者174例,AIH-PBC重叠综合征患者26例,获得随访病例78例。按照是否合并LA分为LA组70例,无淋巴结肿大（NLA）组182例。一般资料、实验室检查指标、影像学检查及随访结果符合正态分布的计量资料以均数±标准差（x±s）表示,组间比较采用t检验;不符合正态分布则以中位数（最小值最大值）表示,组间比较采用Wilcoxon秩和检验;计数资料以率表示,组间比较采用χ2检验、矫正χ2检验或Fisher确切概率法分析。结果 2组在年龄、性别比例、因体检发现肝功能异常而诊断的比例及合并其他自身免疫性疾病的发生率间差异均无统计意义。AIH、PBC及AIH-PBC重叠综合征腹腔LA的发生率分别为21.2%（11/52）,26.4%（46/174）,5...
- 肝炎,自身免疫性 /
- 胆管炎,胆汁性 /
- 重叠综合征 /
- 淋巴系统疾病 /
- 临床特征
Abstract:
Objective To investigate the clinical features of autoimmune liver disease (AILD) complicated by abdominal lymphadenectasis (LA) , as well as the clinical significance of LA in AILD.Methods A retrospective analysis was performed for the clinical data of 252 patients who were admitted to The First Affiliated Hospital of Dalian Medical University from January 2005 to April 2016, and among these patients, 52 had autoimmune hepatitis (AIH) , 174 had primary biliary cholangitis (PBC) , and 26 had AIH-PBC overlap syndrome (AIH-PBC OS) .A total of 78 patients underwent follow-up.According to the presence or absence of LA, these patients were divided into LA group with 70 patients and non-LA (NLA) group with 182 patients.As for general information, laboratory markers, imaging findings, and follow-up results, the normally distributed continuous data were expressed as mean±SD, and the t-test was used for comparison between groups;the non-normally distributed continuous data were expressed as median, and the Wilcoxon rank sum test was used for comparison between groups.The categorical data were expressed as rates, and the chi-square test, the corrected chi-square test, or the Fisher's exact test was used for comparison of these data between groups.Results There were no significant differences between the two groups in age, sex ratio, proportion of patients who were diagnosed due to abnormal liver function found by physical examination, and incidence rates of other autoimmune diseases.The incidence rate of abdominal LA was 22% (11/52) in the AIH group, 26.4% (46/174) in the PBC group, and50% (13/26) in the AIH-PBC OS group, and the AIH-PBC OS group had a significantly higher incidence rate than the AIH group and the PBC group (χ2=7.693, P=0.021) .The LA group had significantly higher levels of alkaline phosphatase and gamma-glutamyl transpeptidase (GGT) than the NLA group (Z=2.944 and 3.169, P=0.003 and 0.002) .For the patients with PBC, the LA group had a significantly higher level of GGT than the NLA group (Z=2.136, P=0.033) ;for the patients with AIH-PBC OS, the LA group had a significantly higher level of total bilirubin than the NLA group (Z=2.121, P=0.035) ;for the patients with AIH, there were no significant differences in these indices between the LA group and the NLA group.The LA group had a higher incidence rate of abnormal imaging findings than the NLA group (97.1% vs 81.9%, χ2=9.863, P=0.002) .A total of 78 patients were followed up with a median follow-up time of 18 months.Of all patients in the LA group, 6 (23.1%) achieved complete remission, 7 (26.9%) achieved incomplete response, 1 (3.8%) experienced recurrence, and 12 (46.2%) experienced treatment failure;of all patients in the NLA group, 21 (40.4%) achieved complete remission, 17 (32.7%) achieved incomplete response, 7 (13.5%) experienced recurrence, and 7 (13.5%) experienced treatment failure;there was a significant difference in the distribution of treatment outcomes between the LA group and the NLA group (Z=2.406, P=0.016) .Conclusion Patients with AIH-PBC OS have a higher incidence rate of abdominal LA than those with AIH and PBC, and patients with AILD complicated by LA may have marked cholestasis and liver impairment and poor treatment response, suggesting that LA might be used to determine disease severity and judge prognosis.
- hepatitis, autoimmune /
- cholangitis, biliary /
- AIH-PBC overlap syndrome /
- lymphatic diseases /
- clinical feature

HTML全文

参考文献(22)

[1]BUNCHORNTAVAKUL C, REDDY KR.Diagnosis and management of overlap syndromes[J].Clin Liver Dis, 2015, 19 (1) :81-97.

[2]DIETRICH CF, LEE J-H, HERRMANN G, et al.Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C[J].Hepatology, 1997, 26 (2) :467-472.

[3]CZAJA AJ.Diagnosis and management of autoimmune hepatitis[J].Clin Liver Dis, 2015, 19 (1) :57-79.

[4]ALI AH, CAREY EJ, LINDOR KD.Diagnosis and management of primary biliary cirrhosis[J].Exp Rev Clin Immunol, 2014, 10 (12) :1667-1678.

[5]CHAZOUILLERES O, WENDUM D, SERFATY L, et al.Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:clinical features and response to therapy[J].Hepatology, 1998, 28 (2) :296-301.

[6]YANG MH, YOU H.Criteria for biochemical response in patients with primary biliary cirrhosis treated with ursodeoxycholic acid and research advances in its treatment[J].J Pract Hepatol, 2013, 16 (2) :169-171. (in Chinese) 杨梦晗, 尤红.熊去氧胆酸治疗原发性胆汁性肝硬化生化应答标准及治疗研究进展[J].实用肝脏病杂志, 2013, 16 (2) :169-171.

[7]MA H, ZHANG J, WANG BM.Analysis of clinical features and efficacy of 44 cases of primary biliray cirrhosis-autoimmune hepatitis overlap syndrome[J].Chin J Dig, 2012, 32 (4) :236-240. (in Chinese) 马欢, 张洁, 王邦茂.原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征44例临床特点及疗效分析[J].中华消化杂志, 2012, 32 (4) :236-240.

[8]WERNERA M, PRYTZB H, OHLSSONC B, et al.Epidemiology and the initial presentation of autoimmune hepatitis in Sweden:a nationwide study[J].Scand J Gastroenterol, 2008, 43 (10) :1232-1240.

[9]CHUANG N, GROSS RG, ODIN JA.Update on the epidemiology of primary biliary cirrhosis[J].Exp Rev Gastroenterol Hepatol, 2011, 5 (5) :583-590.

[10]LIN JS, YU JL.The progress in clinical diagnosis and treatment for overlap syndrome of autoimmune liver diseases[J].Chin J Hepatol, 2010, 18 (5) :332-334. (in Chinese) 林菊生, 余金玲.自身免疫性肝病重叠综合征的临床诊治进展[J].中华肝脏病杂志, 2010, 18 (5) :332-334.

[11]SILVEIRA MG, TALWALKAR JA, ANGULO P, et al.Overlap of autoimmune hepatitis and primary biliary cirrhosis:long-term outcomes[J].Am J Gastroenterol, 2007, 102 (6) :1244-1250.

[12]DODD GD 3rd, BARON RL, OLIVER JH 3rd, et al.Enlarged abdominal lymph nodes in end-stage cirrhosis:CT-histopathologic correlation in 507 patients[J].Radiology, 1997, 203 (1) :127-130.

[13]MANNS MP, CZAJA AJ, GORHAM JD, et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.

[14]SAHEBJAM F, VIERLING JM.Autoimmune hepatitis[J].Front Med, 2015, 9 (2) :187-219.

[15]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.

[16]LYTTKENS K, PRYTZ H, FORSBERG L, et al.Ultrasound, hepatic lymph nodes and chronic active hepatitis[J].J Hepatol, 1994, 21 (4) :578-581.

[17]JIAO GH, ZHOU L, ZHANG J, et al.Clinical features of primary biliary cirrhosis complicated by abdominal lymphadenectasis:an analysis of 67 cases[J].Chin J Dig, 2015, 35 (11) :770-772. (in Chinese) 焦国慧, 周璐, 张洁, 等.伴有腹腔淋巴结肿大的原发性胆汁性肝硬化67例临床特征分析[J].中华消化杂志, 2015, 35 (11) :770-772.

[18]MULLER P, RENOU C, HARAFA A, et al.Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host[J].J Hepatol, 2003, 39 (5) :807-813.

[19]LYTTKENSA K, PRYTZA H, FORSBERGA L, et al.Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis.An ultrasound study[J].Scand J Gastroenterol, 1995, 30 (10) :1036-1040.

[20]FUJII H.Case of autoimmune hepatitis with markedly enlarged hepatoduodenal ligament lymph nodes[J].World J Gastroenterol, 2013, 19 (11) :1834.

[21]HIRSCHFIELD GM, GERSHWIN ME.The immunobiology and pathophysiology of primary biliary cirrhosis[J].Annu Rev Pathol, 2013, 8 (1) :303-330.

[22]EUSTACE S, BUFF B, KANE R, et al.The prevalence and clinical significance of lymphadenopathy in primary biliary cirrhosis[J].Clin Radiol, 1995, 50 (6) :396-399.

施引文献

资源附件(0)

访问统计